Cargando…
USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
Colon adenocarcinoma (COAD) is one of the diseases with the highest morbidity and mortality in the world. At present, immunotherapy has become a valuable method for the treatment of COAD. Tumor mutational burden (TMB) is considered to be the most common biomarker for predicting immunotherapy. Accord...
Autores principales: | Sun, Yuanyuan, Li, Long, Yao, Wenchao, Liu, Xuxu, Yang, Yang, Ma, Biao, Xue, Dongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593250/ https://www.ncbi.nlm.nih.gov/pubmed/34795697 http://dx.doi.org/10.3389/fgene.2021.762160 |
Ejemplares similares
-
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021) -
Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
por: Peng, Linglong, et al.
Publicado: (2021) -
Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations
por: Garcia-Garcia, Gema, et al.
Publicado: (2011) -
Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer
por: Lv, Zhenyi, et al.
Publicado: (2022) -
Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
por: Zhou, Zhangjian, et al.
Publicado: (2021)